AGM/EGMJun 30, 2026, 05:01 PM
RenovoRx Stockholders Approve Incentive Plan, Elect Directors
AI Summary
RenovoRx, Inc. held its 2026 annual meeting of stockholders on June 30, 2026. During the meeting, stockholders elected six directors to serve for a one-year term. Additionally, an amendment to the 2021 Omnibus Equity Incentive Plan was approved, adding 2,000,000 shares of common stock, representing 4.4% of total outstanding shares, to the plan. Stockholders also ratified the appointment of Frank, Rimerman + Co. LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.
Key Highlights
- Six directors, including Shaun R. Bagai and Ramtin Agah, M.D., were elected for a one-year term.
- Stockholders approved adding 2,000,000 shares to the 2021 Omnibus Equity Incentive Plan.
- The added shares represent 4.4% of the total issued and outstanding common stock.
- The incentive plan amendment was approved with 9,666,218 votes for.
- Frank, Rimerman + Co. LLP was ratified as the independent auditor for 2026 with 21,938,316 votes for.
- A quorum was established with approximately 22,825,465 shares of voting stock present or represented.
- The total voting stock outstanding as of the record date was 45,052,706 shares.
Price Impact
More from RNXT